Dongyin Yu

2.3k total citations
9 papers, 685 citations indexed

About

Dongyin Yu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dongyin Yu has authored 9 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Dongyin Yu's work include Angiogenesis and VEGF in Cancer (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Dongyin Yu is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Dongyin Yu collaborates with scholars based in United States and Japan. Dongyin Yu's co-authors include Jonathan D. Oliner, Angela Coxon, Stéphane Richard, Patricia A. Connelly, Andréy S. Shaw, Michael W. Olszowy, Kendall Blumer, James Bready, Hiroya Hashizume and Beverly L. Falcón and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Developmental Biology.

In The Last Decade

Dongyin Yu

9 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dongyin Yu United States	7	498	194	151	82	63	9	685
Antreas Hindoyan United States	11	409 0.8×	365 1.9×	128 0.8×	93 1.1×	68 1.1×	24	767
Anil Sadarangani United States	15	648 1.3×	183 0.9×	270 1.8×	54 0.7×	34 0.5×	32	970
Yvonne Parker United States	13	378 0.8×	194 1.0×	223 1.5×	142 1.7×	124 2.0×	24	734
Jeannine Diesch Australia	15	591 1.2×	155 0.8×	152 1.0×	67 0.8×	35 0.6×	20	852
Kimberly Lezon-Geyda United States	16	473 0.9×	162 0.8×	200 1.3×	168 2.0×	43 0.7×	34	860
Emma Rennel United Kingdom	13	669 1.3×	125 0.6×	157 1.0×	76 0.9×	54 0.9×	14	954
Clara Guerzoni Italy	13	638 1.3×	203 1.0×	153 1.0×	105 1.3×	36 0.6×	18	982
Carmine Fedele United States	12	628 1.3×	280 1.4×	214 1.4×	142 1.7×	48 0.8×	16	870
Nina Sausgruber Switzerland	8	478 1.0×	144 0.7×	85 0.6×	103 1.3×	46 0.7×	9	707
Mathilde Romagnoli France	15	361 0.7×	226 1.2×	161 1.1×	52 0.6×	48 0.8×	24	584

Countries citing papers authored by Dongyin Yu

Since Specialization

Citations

This map shows the geographic impact of Dongyin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyin Yu more than expected).

Fields of papers citing papers by Dongyin Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyin Yu. The network helps show where Dongyin Yu may publish in the future.

Co-authorship network of co-authors of Dongyin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyin Yu. A scholar is included among the top collaborators of Dongyin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyin Yu. Dongyin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Canon, Jude, Tao Osgood, Steven H. Olson, et al.. (2015). The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents. Molecular Cancer Therapeutics. 14(3). 649–658. 116 indexed citations

Payton, Marc, Dongyin Yu, Raffi Manoukian, et al.. (2014). Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method. Laboratory Investigation. 94(11). 1296–1308. 5 indexed citations

Wang, Xiaoen, Andrea J. Bullock, Liang Zhang, et al.. (2014). The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma. Translational Oncology. 7(2). 188–195. 34 indexed citations

Bready, James, Kyung Lee, Kevin C. Graham, et al.. (2014). Abstract 1022: Development and preclinical testing of AMG 780, a fully human antibody targeting angiopoietin 1 (Ang1) and angiopoietin 2 (Ang2). Cancer Research. 74(19_Supplement). 1022–1022. 3 indexed citations

Saiki, Anne Y., Sean Caenepeel, Dongyin Yu, et al.. (2014). MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways. Oncotarget. 5(8). 2030–2043. 45 indexed citations

Hashizume, Hiroya, Beverly L. Falcón, Peter Bałuk, et al.. (2010). Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth. Cancer Research. 70(6). 2213–2223. 192 indexed citations

Beck, Hilary P., Brian M. Fox, John G. Allen, et al.. (2010). Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2752–2755. 29 indexed citations

Nakayama, Naoki, Sheila Scully, Ryuichi Nishinakamura, et al.. (2001). A Novel Chordin-like Protein Inhibitor for Bone Morphogenetic Proteins Expressed Preferentially in Mesenchymal Cell Lineages. Developmental Biology. 232(2). 372–387. 76 indexed citations

Richard, Stéphane, Dongyin Yu, Kendall Blumer, et al.. (1995). Association of p62, a Multifunctional SH2- and SH3-Domain-Binding Protein, with src Family Tyrosine Kinases, Grb2, and Phospholipase Cγ-1. Molecular and Cellular Biology. 15(1). 186–197. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact